Research / BLZE / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-051818 General Corporate
Capex intensity 39th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.88% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
24.41% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
17.67% · CORE · VALID
Gross margin 95th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.gross_margin
62.82% · CORE · VALID
Operating margin 95th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
-9.77% · CORE · VALID
R&D intensity 0th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
25.76% · OPTIONAL · VALID
SBC intensity 68th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
21.44% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/4 normalized Level 3 Dec 31, 2021 0/6 normalized Level 3 Mar 31, 2022 0/6 normalized Level 3 Jun 30, 2022 0/6 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/7 normalized Level 3 Mar 31, 2023 0/7 normalized Level 3 Jun 30, 2023 0/7 normalized Level 3 Sep 30, 2023 4/7 normalized Level 3 Dec 31, 2023 6/7 normalized Level 3 Mar 31, 2024 6/7 normalized Level 3 Jun 30, 2024 6/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 1.68%
Current 1.88%
Delta 0.19% Cash Generation Increased
Previous 8.69%
Current 24.41%
Delta 15.72% Growth Increased
Previous 11.71%
Current 17.67%
Delta 5.96% Margin Increased
Previous 60.85%
Current 62.82%
Delta 1.97% Profitability Increased
Previous -13.84%
Current -9.77%
Delta 4.07% R And D Intensity Decreased
Previous 29.19%
Current 25.76%
Delta -3.43% Sbc Intensity Increased
Previous 17.85%
Current 21.44%
Delta 3.59% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jun 30, 2025
Similarity 81%
Compared 7 dimensions
Coverage 100% Growth 21.8 · Margin 5.3 · Profitability 5.3 · Sbc Intensity 21.8 · Capex Intensity 4.0 · Cash Generation 28.6 · R And D Intensity 26.7 Dec 31, 2024
Similarity 79%
Compared 7 dimensions
Coverage 100% Growth 4.4 · Margin 10.1 · Profitability 25.5 · Sbc Intensity 0.8 · Capex Intensity 22.2 · Cash Generation 16.7 · R And D Intensity 38.5 Dec 31, 2025
Similarity 77%
Compared 7 dimensions
Coverage 100% Growth 32.3 · Margin 6.5 · Profitability 0.6 · Sbc Intensity 44.9 · Capex Intensity 11.1 · Cash Generation 0.0 · R And D Intensity 23.5 Mar 31, 2024
Similarity 75%
Compared 6 dimensions
Coverage 86% Margin 4.7 · Profitability 14.7 · Sbc Intensity 48.4 · Capex Intensity 27.8 · Cash Generation 0.0 · R And D Intensity 20.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.